Literature DB >> 29240241

Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion.

A T G Chiu1,2, S L C Pei1, C C Y Mak1, G K C Leung1, M H C Yu1, S L Lee1,2, M Vreeburg3, R Pfundt4, I van der Burgt4, T Kleefstra4,5, T M-T Frederic6,7,8, S Nambot6,7, L Faivre6, A-L Bruel8, M Rossi9,10, B Isidor11,12, S Küry11, B Cogne11, T Besnard11, M Willems13, M R F Reijnders4,5, B H Y Chung1,2.   

Abstract

Okur-Chung syndrome is a neurodevelopmental condition attributed to germline CSNK2A1 pathogenic missense variants. We present 8 unreported subjects with the above syndrome, who have recognizable dysmorphism, varying degrees of developmental delay and multisystem involvement. Together with 6 previously reported cases, we present a case series of 7 female and 7 male subjects, highlighting the recognizable facial features of the syndrome (microcephaly, hypertelorism, epicanthic fold, ptosis, arched eyebrows, low set ears, ear fold abnormality, broad nasal bridge and round face) as well as frequently occurring clinical features including neurodevelopmental delay (93%), gastrointestinal (57%), musculoskeletal (57%) and immunological (43%) abnormalities. The variants reported in this study are evolutionary conserved and absent in the normal population. We observed that the CSNK2A1 gene is relatively intolerant to missense genetic changes, and most variants are within the protein kinase domain. All except 1 variant reported in this cohort are spatially located on the binding pocket of the holoenzyme. We further provide key recommendations on the management of Okur-Chung syndrome. To conclude, this is the second case series on Okur-Chung syndrome, and an in-depth review of the phenotypic features and genomic findings of the condition with suggestions on clinical management.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990CSNK2A1; Okur-Chung syndrome; developmental delay; whole exome sequencing

Mesh:

Substances:

Year:  2018        PMID: 29240241     DOI: 10.1111/cge.13196

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  14 in total

1.  Increased diagnostic and new genes identification outcome using research reanalysis of singleton exome sequencing.

Authors:  Ange-Line Bruel; Sophie Nambot; Virginie Quéré; Antonio Vitobello; Julien Thevenon; Mirna Assoum; Sébastien Moutton; Nada Houcinat; Daphné Lehalle; Nolwenn Jean-Marçais; Martin Chevarin; Thibaud Jouan; Charlotte Poë; Patrick Callier; Emilie Tisserand; Christophe Philippe; Frédéric Tran Mau Them; Yannis Duffourd; Laurence Faivre; Christel Thauvin-Robinet
Journal:  Eur J Hum Genet       Date:  2019-06-23       Impact factor: 4.246

2.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

3.  Overrepresentation of genetic variation in the AnkyrinG interactome is related to a range of neurodevelopmental disorders.

Authors:  Ilse M van der Werf; Sandra Jansen; Petra F de Vries; Amber Gerstmans; Maartje van de Vorst; Anke Van Dijck; Bert B A de Vries; Christian Gilissen; Alexander Hoischen; Lisenka E L M Vissers; R Frank Kooy; Geert Vandeweyer
Journal:  Eur J Hum Genet       Date:  2020-07-10       Impact factor: 4.246

4.  Are CSNK2A1 gene mutations associated with retinal dystrophy? Report of a patient carrier of a novel de novo splice site mutation.

Authors:  Davide Colavito; Elda Del Giudice; Chiara Ceccato; Maurizio Dalle Carbonare; Alberta Leon; Agnese Suppiej
Journal:  J Hum Genet       Date:  2018-03-22       Impact factor: 3.172

5.  Dissection of mendelian predisposition and complex genetic architecture of craniovertebral junction malformation.

Authors:  Zhenlei Liu; Huakang Du; Hengqiang Zhao; Siyi Cai; Sen Zhao; Yuchen Niu; Xiaoxin Li; Bowen Liu; Yingzhao Huang; Jiashen Shao; Lian Liu; Ye Tian; Zhihong Wu; Hao Wu; Yue Hu; Terry Jianguo Zhang; Fengzeng Jian; Nan Wu
Journal:  Hum Genet       Date:  2022-09-13       Impact factor: 5.881

6.  Protein kinase CK2 phosphorylates a conserved motif in the Notch effector E(spl)-Mγ.

Authors:  Lucas M Jozwick; Ashok P Bidwai
Journal:  Mol Cell Biochem       Date:  2022-09-10       Impact factor: 3.842

7.  Persistent Hyperplastic Primary Vitreous with Microphthalmia and Coloboma in a Patient with Okur-Chung Neurodevelopmental Syndrome.

Authors:  Hiroaki Murakami; Tomoko Uehara; Yumi Enomoto; Naoto Nishimura; Tatsuro Kumaki; Yukiko Kuroda; Mizuki Asano; Noriko Aida; Kenjiro Kosaki; Kenji Kurosawa
Journal:  Mol Syndromol       Date:  2021-09-22

Review 8.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

9.  Identification of novel CSNK2A1 variants and the genotype-phenotype relationship in patients with Okur-Chung neurodevelopmental syndrome: a case report and systematic literature review.

Authors:  Ruo-Hao Wu; Wen-Ting Tang; Kun-Yin Qiu; Xiao-Juan Li; Dan-Xia Tang; Zhe Meng; Zhan-Wen He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

10.  Structural and Enzymological Evidence for an Altered Substrate Specificity in Okur-Chung Neurodevelopmental Syndrome Mutant CK2αLys198Arg.

Authors:  Christian Werner; Alexander Gast; Dirk Lindenblatt; Anna Nickelsen; Karsten Niefind; Joachim Jose; Jennifer Hochscherf
Journal:  Front Mol Biosci       Date:  2022-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.